NEW YORK, May 4 (GenomeWeb News) - Beckman Coulter today reported a 7-percent increase in first-quarter revenues and a 16-percent jump in net earnings.
Revenues for the quarter ended March 31 increased to $576.1 million from $536.8 million during the same period last year. Both the company's Clinical Diagnostics and Biomedical Research divisions contributed about equally to this increase.
Research and development costs remained flat at $48 million.
Beckman's net income for the quarter increased to $41.4 million, or $.62 per share, from $35.6 million, or $.54 per share, during the same period last year.
As of March 31, Beckman Coulter had $105.2 million in cash and cash equivalents.